Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma March 31, 2015 Department of Oncology, NorLux Neuro-Oncology Laboratory, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg For all author emails, please log on.